学者石控股公司
US ˙ NasdaqGS ˙ US80706P1030

介绍

本页面提供了有关 Edward H Myles 已知的内部交易历史的全面分析。内部人士包括公司的高管、董事或重要投资者。一般而言,基于内幕、非公开信息进行交易是非法的。这并不意味着他们在自己的公司进行任何交易都是非法的。但是,他们必须通过Form 4向美国证券交易委员会(SEC)报告所有交易。尽管存在这些限制,学术研究表明,整体而言,内部人士在自己公司中的投资表现往往优于市场。

平均交易盈利能力

“平均交易盈利能力”衡量了内部人士在过去三年中所有非计划性的公开市场买入交易的平均回报率。计算过程包括检查每笔交易,排除了作为10b5-1交易计划的一部分的交易。然后,对每笔交易在3、6和12个月的表现进行平均,以生成该笔交易最终的表现指标。然后,将所有交易的表现指标进行平均,计算出内部人士的总体平均表现指标。列表仅包含在过去两年中进行过至少三笔交易的内部人士。

如果内部人士的交易盈利能力显示为"N/A",则可能是因为该内部人士在过去三年内没有进行任何公开市场买入交易,或者他们进行的交易距离现在时间太近,无法计算出可靠的表现指标。

更新频率:每日

查看收益最高的的内幕交易者列表。

报告内部持仓的公司

美国证券交易委员会(SEC)文件显示Edward H Myles已报告在以下公司拥有持仓或进行了交易:

证券 职位 最新报告的持仓
US:SRRK / Scholar Rock Holding Corporation COO & CFO 111,345
US:00163UAA4 / AMAG Pharmaceuticals, Inc. 2.5% Bond Due 2/15/2019 COO & CFO 45,000
US:OCAT / Ocata Therapeutics, Inc. COO & CFO 0
如何解读这些图表

以下图表显示了在Edward H Myles进行的每笔公开市场非计划交易后证券的股价表现。非计划交易是指没有作为10b5-1交易计划的一部分而进行的交易。股价表现以累积百分比变化的方式绘制。例如,如果一笔内部人士交易是在2019年1月1日进行的,该图表将显示该证券的每日百分比变化直至当前日期。如果在此期间股价从10美元涨至15美元,则股价的累积百分比变化将为50%。从10美元涨至20美元的价格变化将为100%,而从10美元跌至5美元的价格变化将为-50%。

最终,我们将评估内部人士的交易与股价的超额回报(正向或负向)之间的相关性,以判断内部人士是否在交易中利用内部信息获利。如果内部人士有这样的行为,我们预期看到(a)买入后的正回报,或者(b)卖出后的负回报。对于情况(a),买入图表将显示一系列向上倾斜的曲线,表示每次买入后都有正回报。对于情况(b),卖出图表将显示一系列向下倾斜的曲线,表示每次卖出后都有负回报。

然而,仅凭这一点还不足以得出结论。例如,如果公司的股价在多年内呈现非周期性上升,我们会预期所有买入后的图表都呈现向上倾斜。同样地,多年来呈现非周期性下降的股价会导致卖出后的图表也呈现向下倾斜。这两种情况的图表都不能表示内部人士在进行内幕交易。

最有力的指标是在公司股价呈极度循环波动的情况下,“买入”图表显示正向信号,而“卖出”图表显示负向趋势。这种情况强烈暗示内部人士可能根据内幕信息精确地计时进行交易,以获得财务优势。

SRRK / Scholar Rock Holding Corporation内部人士买入 - 短期收益分析

在这一部分,我们分析了在 SRRK / Scholar Rock Holding Corporation 中进行的每笔非计划的公开市场内部人士买入的盈利情况。这种分析有助于了解内部人士是否持续产生异常的回报,以及是否值得跟踪。该分析基于每笔交易后一年的情况,结果仅为理论值

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期 股票代码 内部人士 报告
股数
报告
价格
经调整
股数
经调整
价格
成本基础 达到最高利润的
天数
达到最高利润时的
价格
最高
利润($)
最高回报率(%)
当前未知该内部人士进行过任何未预先计划的公开市场交易。

经调整价格 已按拆股调整。经调整股数 已按拆股调整。

SRRK / Scholar Rock Holding Corporation Insider Trades
SRRK / Scholar Rock Holding Corporation内部人士卖出 - 短期亏损分析

在这一部分,我们分析了在 SRRK / Scholar Rock Holding Corporation 中进行的每笔非计划的公开市场内部人士卖出所达成的短期亏损规避。如果存在持续的亏损规避模式,可能表明未来的内部人士卖出交易预示着价格的下跌。该分析基于每笔交易后一年的情况,

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期 股票代码 内部人士 报告
股数
报告
价格
经调整
股数
经调整
价格
成本基础 达到最低利润的
天数
达到最低利润时的
价格
避免的
最高损失金额($)
避免的
最高损失率($)
2025-02-18 SRRK Myles Edward H 7,809 36.8290 7,809 36.8290 287,598 49 24.4700 -96,511 -33.56
2025-01-16 SRRK Myles Edward H 12,539 44.1972 12,539 44.1972 554,189
2024-06-17 SRRK Myles Edward H 9,458 8.9848 9,458 8.9848 84,978
2024-02-16 SRRK Myles Edward H 4,744 15.7432 4,744 15.7432 74,686
2024-01-16 SRRK Myles Edward H 6,634 15.9285 6,634 15.9285 105,670

经调整价格 已按拆股调整。经调整股数 已按拆股调整。

SRRK / Scholar Rock Holding Corporation Insider Trades
内幕交易历史

该表格显示了由 Edward H Myles 进行的所有内幕交易的完整列表,这些交易已向美国证券交易委员会(SEC)披露。

备案日期 交易日期 表格 股票代码 证券 代码 10b5-1 股数 剩余股数 %
变化
每股
股价
交易
金额
剩余
金额
2025-03-12 2025-03-10 4 SRRK Scholar Rock Holding Corp
Common Stock
S - Sale X -29,395 111,345 -20.89 34.87 -1,025,004 3,882,600
2025-03-12 2025-03-10 4 SRRK Scholar Rock Holding Corp
Common Stock
S - Sale X -112,897 140,740 -44.51 35.82 -4,043,971 5,041,307
2025-03-12 2025-03-10 4 SRRK Scholar Rock Holding Corp
Common Stock
M - Exercise X 17,857 253,637 7.57 15.75 281,248 3,994,783
2025-03-12 2025-03-10 4 SRRK Scholar Rock Holding Corp
Common Stock
M - Exercise X 5,313 235,780 2.31 10.00 53,130 2,357,800
2025-03-12 2025-03-10 4 SRRK Scholar Rock Holding Corp
Common Stock
M - Exercise X 24,915 230,467 12.12 4.86 121,087 1,120,070
2025-03-12 2025-03-10 4 SRRK Scholar Rock Holding Corp
Common Stock
M - Exercise X 43,122 205,552 26.55 18.08 779,646 3,716,380
2025-03-12 2025-03-10 4 SRRK Scholar Rock Holding Corp
Common Stock
M - Exercise X 21,690 162,430 15.41 13.83 299,973 2,246,407
2025-02-20 2025-02-18 4 SRRK Scholar Rock Holding Corp
Common Stock
S - Sale -7,809 140,740 -5.26 36.83 -287,598 5,183,313
2025-01-21 2025-01-16 4 SRRK Scholar Rock Holding Corp
Common Stock
S - Sale -12,539 148,549 -7.78 44.20 -554,189 6,565,450
2024-10-10 2024-10-08 4 SRRK Scholar Rock Holding Corp
Common Stock
S - Sale X -37,187 161,088 -18.76 34.90 -1,297,659 5,621,246
2024-10-10 2024-10-08 4 SRRK Scholar Rock Holding Corp
Common Stock
M - Exercise X 37,187 198,275 23.08 10.00 371,870 1,982,750
2024-10-07 2024-10-07 4 SRRK Scholar Rock Holding Corp
Common Stock
S - Sale X -31,250 161,088 -16.25 29.05 -907,812 4,679,606
2024-10-07 2024-10-07 4 SRRK Scholar Rock Holding Corp
Common Stock
S - Sale X -25,812 192,338 -11.83 27.27 -703,893 5,245,057
2024-10-07 2024-10-07 4 SRRK Scholar Rock Holding Corp
Common Stock
S - Sale X -37,206 218,150 -14.57 26.83 -998,237 5,852,964
2024-10-07 2024-10-07 4 SRRK Scholar Rock Holding Corp
Common Stock
S - Sale X -111,972 255,356 -30.48 25.61 -2,867,603 6,539,667
2024-10-07 2024-10-07 4 SRRK Scholar Rock Holding Corp
Common Stock
M - Exercise X -206,240 367,328 -35.96 13.83 -2,852,299 5,080,146
2024-06-18 2024-06-17 4 SRRK Scholar Rock Holding Corp
Common Stock
S - Sale -9,458 201,518 -4.48 8.98 -84,978 1,810,599
2024-02-21 2024-02-16 4 SRRK Scholar Rock Holding Corp
Common Stock
S - Sale -4,744 210,976 -2.20 15.74 -74,686 3,321,437
2024-02-13 2024-02-12 4 SRRK Scholar Rock Holding Corp
Common Stock
A - Award 53,570 215,720 33.04
2024-01-18 2024-01-16 4 SRRK Scholar Rock Holding Corp
Common Stock
S - Sale -6,634 162,150 -3.93 15.93 -105,670 2,582,806
2023-12-29 2023-12-29 4 SRRK Scholar Rock Holding Corp
Common Stock
S - Sale X -300 168,784 -0.18 19.51 -5,853 3,292,976
2023-12-29 2023-12-29 4 SRRK Scholar Rock Holding Corp
Common Stock
S - Sale X -12,159 169,084 -6.71 18.82 -228,780 3,181,434
2023-12-29 2023-12-29 4 SRRK Scholar Rock Holding Corp
Common Stock
M - Exercise X 12,459 181,243 7.38 4.86 60,551 880,841
2023-12-08 2023-12-07 4 SRRK Scholar Rock Holding Corp
Common Stock
S - Sale X -24,914 168,784 -12.86 17.53 -436,820 2,959,307
2023-12-08 2023-12-07 4 SRRK Scholar Rock Holding Corp
Common Stock
M - Exercise X 24,914 193,698 14.76 4.86 121,082 941,372
2023-11-03 2023-11-02 4 SRRK Scholar Rock Holding Corp
Common Stock
S - Sale X -35,007 168,784 -17.18 12.51 -438,039 2,111,977
2023-06-22 2023-06-21 4 SRRK Scholar Rock Holding Corp
Common Stock
F - Taxes -7,138 203,791 -3.38 8.75 -62,456 1,783,130
2023-02-15 2023-02-13 4 SRRK Scholar Rock Holding Corp
Common Stock
A - Award 63,750 210,929 43.31
2023-01-19 2023-01-17 4 SRRK Scholar Rock Holding Corp
Common Stock
F - Taxes -7,043 147,179 -4.57 11.29 -79,503 1,661,401
2022-06-21 2022-06-16 4 SRRK Scholar Rock Holding Corp
Common Stock
A - Award 74,750 154,222 94.06
2022-02-15 2022-02-14 4 SRRK Scholar Rock Holding Corp
Stock Option (Right to Buy)
A - Award 57,500 57,500
2022-02-15 2022-02-14 4 SRRK Scholar Rock Holding Corp
Common Stock
A - Award 57,500 79,472 261.70
2022-01-19 2022-01-18 4 SRRK Scholar Rock Holding Corp
Common Stock
F - Taxes -2,178 21,972 -9.02 19.46 -42,390 427,639
2021-11-15 2021-11-15 4 SRRK Scholar Rock Holding Corp
Stock Option (Right to Buy)
M - Exercise -4,879 187,500 -2.54
2021-11-15 2021-11-15 4 SRRK Scholar Rock Holding Corp
Common Stock
S - Sale X -4,879 24,150 -16.81 35.05 -171,006 846,443
2021-11-15 2021-11-15 4 SRRK Scholar Rock Holding Corp
Common Stock
X - Other X 4,879 29,029 20.20
2021-11-15 2021-11-12 4 SRRK Scholar Rock Holding Corp
Stock Option (Right to Buy
M - Exercise -2,351 192,379 -1.21
2021-11-15 2021-11-12 4 SRRK Scholar Rock Holding Corp
Stock Option (Right to Buy)
M - Exercise -47,497 194,730 -19.61
2021-11-15 2021-11-12 4 SRRK Scholar Rock Holding Corp
Common Stock
S - Sale X -49,848 24,150 -67.36 35.12 -1,750,437 848,039
2021-11-15 2021-11-12 4 SRRK Scholar Rock Holding Corp
Common Stock
X - Other X 49,848 73,998 206.41
2021-11-15 2021-11-11 4 SRRK Scholar Rock Holding Corp
Stock Option (Right to Buy)
M - Exercise -7,773 242,227 -3.11
2021-11-15 2021-11-11 4 SRRK Scholar Rock Holding Corp
Stock Option (Right to Buy)
M - Exercise -5,079 0 -100.00
2021-11-15 2021-11-11 4 SRRK Scholar Rock Holding Corp
Stock Option (Right to Buy)
M - Exercise -10,722 0 -100.00
2021-11-15 2021-11-11 4 SRRK Scholar Rock Holding Corp
Common Stock
S - Sale X -23,574 24,150 -49.40 35.20 -829,857 850,133
2021-11-15 2021-11-11 4 SRRK Scholar Rock Holding Corp
Common Stock
X - Other X 23,574 47,724 97.61
2021-02-03 2021-02-01 4 SRRK Scholar Rock Holding Corp
Stock Option (Right to Buy)
A - Award 80,500 346,301 30.29
2021-02-03 2021-02-01 4 SRRK Scholar Rock Holding Corp
Common Stock
A - Award 24,150 24,150
2020-07-17 2020-07-16 4 SRRK Scholar Rock Holding Corp
Stock Option (Right to Buy)
A - Award 250,000 250,000
2020-06-18 2020-06-16 4 SRRK Scholar Rock Holding Corp
Stock Option (right to buy)
A - Award 13,000 13,000
2020-03-12 2020-03-10 4 AMAG AMAG PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
A - Award 45,000 45,000
2020-03-12 2020-03-10 4 AMAG AMAG PHARMACEUTICALS, INC.
Common Stock
A - Award 30,000 98,659 43.69
2020-03-04 2020-03-02 4 AMAG AMAG PHARMACEUTICALS, INC.
Common Stock
F - Taxes -1,021 68,659 -1.47 7.75 -7,913 532,107
2020-02-25 2020-02-25 4 AMAG AMAG PHARMACEUTICALS, INC.
Common Stock
F - Taxes -1,386 77,180 -1.76 8.84 -12,252 682,271
2020-02-25 2020-02-23 4 AMAG AMAG PHARMACEUTICALS, INC.
Common Stock
F - Taxes -867 78,566 -1.09 9.50 -8,236 746,377
2019-05-23 2019-05-21 4 SRRK Scholar Rock Holding Corp
Stock Option (Right to Buy)
A - Award 5,079 5,079
2019-04-12 2019-04-11 4 AMAG AMAG PHARMACEUTICALS INC.
Common Stock
F - Taxes -1,964 79,433 -2.41 12.47 -24,491 990,530
2019-03-05 2019-03-02 4 AMAG AMAG PHARMACEUTICALS INC.
Common Stock
F - Taxes -1,064 81,397 -1.29 14.76 -15,705 1,201,420
2019-02-27 2019-02-25 4 AMAG AMAG PHARMACEUTICALS INC.
Stock Option (Right to Buy)
A - Award 25,000 25,000
2019-02-27 2019-02-25 4 AMAG AMAG PHARMACEUTICALS INC.
Common Stock
A - Award 20,000 82,461 32.02
2019-02-27 2019-02-25 4 AMAG AMAG PHARMACEUTICALS INC.
Common Stock
A - Award 12,000 62,461 23.78
2019-02-26 2019-02-23 4 AMAG AMAG PHARMACEUTICALS INC.
Common Stock
F - Taxes -869 50,461 -1.69 15.51 -13,478 782,650
2018-11-21 2018-11-19 4 SRRK Scholar Rock Holding Corp
Stock Option (right to buy)
A - Award 20,316 20,316
2018-07-03 2018-07-02 4 AMAG AMAG PHARMACEUTICALS INC.
Common Stock
F - Taxes -1,964 51,330 -3.69 19.85 -38,985 1,018,900
2018-03-06 2018-03-02 4 AMAG AMAG PHARMACEUTICALS INC.
Stock Option (Right to Buy)
A - Award 24,000 24,000
2018-03-06 2018-03-02 4 AMAG AMAG PHARMACEUTICALS INC.
Common Stock
F - Taxes -854 53,294 -1.58 21.00 -17,934 1,119,174
2018-03-06 2018-03-02 4 AMAG AMAG PHARMACEUTICALS INC.
Common Stock
A - Award 10,000 54,148 22.65
2018-03-06 2018-03-02 4 AMAG AMAG PHARMACEUTICALS INC.
Common Stock
A - Award 10,000 54,148 22.65
2017-05-10 2017-05-08 4 AMAG AMAG PHARMACEUTICALS INC.
Common Stock
F - Taxes -2,177 32,823 -6.22 18.55 -40,383 608,867
2017-02-27 2017-02-23 4 AMAG AMAG PHARMACEUTICALS INC.
Stock Option (Right to Buy)
A - Award 20,000 20,000
2017-02-27 2017-02-23 4 AMAG AMAG PHARMACEUTICALS INC.
Common Stock
A - Award 7,500 35,000 27.27
2017-02-27 2017-02-23 4 AMAG AMAG PHARMACEUTICALS INC.
Common Stock
A - Award 7,500 35,000 27.27
2016-04-11 2016-04-11 4 AMAG AMAG PHARMACEUTICALS INC.
Stock Option (Right to Buy)
A - Award 35,000 35,000
2016-04-11 2016-04-11 4 AMAG AMAG PHARMACEUTICALS INC.
Common Stock
A - Award 20,000 20,000
2016-04-11 3 AMAG AMAG PHARMACEUTICALS INC.
No securities beneficially owned
0
2016-02-11 2016-02-10 4 OCAT Ocata Therapeutics, Inc.
Stock Option (Right to Buy)
D - Sale to Issuer -112,000 0 -100.00
2016-02-11 2016-02-10 4 OCAT Ocata Therapeutics, Inc.
Stock Option (Right to Buy)
D - Sale to Issuer -140,000 0 -100.00
2016-02-11 2016-02-10 4 OCAT Ocata Therapeutics, Inc.
Common Stock
U - Other -56,000 0 -100.00 8.50 -476,000
2014-09-16 2014-09-12 4 ACTCD ADVANCED CELL TECHNOLOGY, INC.
Employee Stock Option (right to buy)
A - Award 112,000 252,000 80.00
2014-09-16 2014-09-12 4 ACTCD ADVANCED CELL TECHNOLOGY, INC.
Common Stock
A - Award 56,000 56,000
2013-07-01 2013-06-27 4 ACTC ADVANCED CELL TECHNOLOGY, INC.
Employee Stock Option (right to buy)
A - Award 14,000,000 14,000,000
P
非衍生或衍生证券的公开市场或私下买入
S
非衍生或衍生证券的公开市场或私下卖出
A
公司向内部人员授予、奖励或以其他方式获取证券(例如股票期权)
C
衍生工具转换
D
将证券卖出或转让回公司
F
使用从公司收到的证券的一部分来支付行使价或税务负担。
G
内部人士赠送或接收他人赠送公司股票
K
股权掉期和类似的避险交易
M
行使或转换从公司获得的衍生证券(例如期权)
V
内部人士通过Form 4自愿报告的一笔交易
J
其他(附有交易描述的脚注)